Back to company

VIAD PHARMA ApS: Financial statements 2025

CVR: 36433892

VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. That is a decrease of 44.1% compared with the year before. Equity amounted to DKK 236,399. The solvency ratio was 11.4%. The company had 1 employee in the financial year.

Gross Profit
1,031,002 kr.
Profit/Loss
168,032 kr.
Equity
236,399 kr.
Total Assets
2,068,658 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-1 mio.168 t.236 t.1
2024-1.8 mio.809 t.877 t.-
2023-1.3 mio.376 t.445 t.-
2022-1 mio.188 t.257 t.-
2021-1 mio.250 t.319 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like VIAD PHARMA ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

VIAD PHARMA ApS: The 2024 annual report is outJan 29, 2025

VIAD PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 1,843,899, and the net result was DKK 808,813.

About VIAD PHARMA ApS

VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity amounted to DKK 236,399.